Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial

Recruiting

Plain-English translation of NCT07738523 on ClinicalTrials.gov ↗ · Source last updated July 2026 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(1 site)

Spain

Getafe University Hospital, Getafe, Madrid

Key details

Phase

Large-scale testing

Sponsor

Hospital Universitario Getafe

Collaborators

Instituto de Investigación Sanitaria Getafe

Enrollment target

~50 participants

Started

July 2026

Primary completion

December 2027

Age range

18 Years – 80 Years

Last updated on clinicaltrials.gov in July 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Martín Negreira-Caamaño, MD, PhD

Hospital Universitario Getafe

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov